Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chromatin status and transcriptomics of HEK293, U2OS, HepG2 and K562

ABSTRACT: RNA-seq, H3K27Ac ChIP-seq, and ATAC-seq data of U2OS, HEK293, HepG2, and K562 cell lines

ORGANISM(S): Homo sapiens

PROVIDER: GSE139190 | GEO | 2020/12/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Chromatin status and transcriptomics of HEK293, U2OS, HepG2 and K562

Project description:Chromatin status and transcriptomics of HEK293, U2OS, HepG2 and K562

| PRJNA578731 | ENA

RNA sequencing of AP1M1 KO HEK293 and U2OS

Project description:AP1M1 is an obligatory member of the AP1 clatherin adaptor complex, important for cellular trafficking. In this study, we investigated the transcriptomic profiles of cells lines (HEK293 and U2OS) in presence and in absence of AP1M1.

2025-05-19 | GSE280430 | GEO

RNA sequencing of AP1M1 KO HEK293 and U2OS

Project description:RNA sequencing of AP1M1 KO HEK293 and U2OS

| PRJNA1178584 | ENA

RNA sequencing of non-targetting ASOs on HEK293 and U2OS cells

Project description:Non-targetting ASOs are commonly used as negative controls in vitro and in vivo. Here, we compare the transcriptomic profile of HEK293 and U2OS, following 3 days treatment with 3 different non-targetting ASOs. In those conditions, we did not find major transcriptomic changes following ASO treatment, confirming that they are appropriate negative controls.

2025-05-19 | GSE280432 | GEO

GNPS-Tissue culture (HT29,HepG2 and HEK293) treatment with chemical conjugates

Project description:HT29, HepG2 and HEK293 cells cultured in DMEM Media were treated with Bileacids and N-acyl lipid conjugates, Data was acquired at time 0hr and 48hr post treatment in a 96-well plate based assay.

2025-04-22 | MSV000097688 | GNPS

RNA sequencing of non-targetting ASOs on HEK293 and U2OS cells

Project description:RNA sequencing of non-targetting ASOs on HEK293 and U2OS cells

| PRJNA1178585 | ENA

Glucocorticoid receptor profiling in IMR90,K562 and U2OS (ChIP-seq)

Project description:To identify the sequences responsible for recruitment of Glucocorticoid receptor (GR) to individual loci, we performed ChIP-seq and ChIP-exo that combines chromatin immunoprecipitation with an exonuclease digestion step. We performed these experiments in three cell lines : IMR90 (ATTC:CCL-186), U2OS osteosarcoma cell lines, K562 (ATCC:CCL243), upon glucocorticoid treatment. The U2OS assays are the same as those in E-MTAB-2731.

2015-02-25 | E-MTAB-2955 | biostudies-arrayexpress

Ribo-seq on K562 and HepG2 cells

Project description:Ribo-seq on K562 and HepG2 cells

| PRJNA529885 | ENA

Transcriptomics profile of polyQ expressing U2OS cells and clofazimine treated polyQ expressing U2OS cells

Project description:To better understand the mechanism by which CFZ impacts polyQ toxicity, we conducted a transcriptomic analysis in polyQ94-EGFP expressing U2OS (5μM, 8 days). Data from a transcriptomics experiment in polyQ94-U2OS cells treated with CFZ (5 μM, 8day) was compared to a DMSO-treated control.

2023-05-11 | GSE222758 | GEO

Glucocorticoid receptor profiling in IMR90, K562 and U2OS (ChIP-exo)

2015-02-25 | E-MTAB-2956 | biostudies-arrayexpress